LTBP2 and idiopathic pulmonary fibrosis: Enomoto et al. (2018) found that LTBP2 was secreted from lung myofibroblasts and was potentially a novel prognostic blood biomarker reflecting the level of differentiation of lung fibroblasts into myofibroblasts in IPF patients.